ReviewIranian journal of public health2023

Application Value of PCSK9 Inhibitor in Cardiovascular High Risk Patients: A Meta-Analysis.

Liming Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.